SCNI
Scinai Immunotherapeutics
SCNI
SCNI
5 hedge funds and large institutions have $164K invested in Scinai Immunotherapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Wells Fargo
San Francisco,
California
|
$6K |
| 2 |
2
Morgan Stanley
New York
|
$2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VIA
1
Vantage Investment Advisors
State College,
Pennsylvania
| $149K | – | – | – |
|
|
2
Wells Fargo
San Francisco,
California
| $6K | +$6K | +7 | New |
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $5K | -$2.5K | -3 | -33% |
|
|
EWM
4
Edge Wealth Management
New York
| $2K | – | – | – |
|
|
5
Morgan Stanley
New York
| $2K | +$2K | +2 | New |
|
6
Citadel Advisors
Miami,
Florida
| – | -$177K | -306 | Closed |
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$83K | -142 | Closed |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | -$1K | -1 | Closed |
|